Noopept: 1000x Piracetam & What That Actually Means
Last updated: October 2026
Noopept (GVS-111) is a synthetic dipeptide nootropic developed in Russia. The "1000x more potent than piracetam" claim is real, but misleading. Here's what the evidence actually shows about mechanism, clinical data, dosing, and realistic expectations.
🧪 Buy Noopept at Swiss Chems →By weight, in animal studies (PMID: 12596521)
2 months (PMID: 22500312)
Raised in rat hippocampus (PMID: 19240853)
Build your own printable peptide tracker
A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.
How Noopept Works
Several mechanisms have been proposed, almost all from Russian animal and cell studies. Beyond glutamate signaling, Noopept has been reported to raise neurotrophic factor expression in rats, a different profile from simple racetams.
Rat studies link Noopept's effects to glutamate receptors. In EEG experiments, an NMDA-receptor blocker reduced or abolished the effects of a single dose, while AMPA receptors were tied to the fading of its EEG effects with repeated dosing (PMID: 21414388). In receptor-binding tests on rat brain tissue, Noopept showed only weak competition at AMPA receptor sites (PMID: 21476267). Glutamate is the main excitatory neurotransmitter in learning and memory, but how these findings translate to cognition in people is not established.
The most-studied feature of Noopept in Russian animal research. In rats, Noopept increased hippocampal mRNA for BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor) after a single dose, and the effect persisted over 28 days of treatment (PMID: 19240853); a later rat study also reported higher BDNF expression after chronic dosing (PMID: 21395007). These proteins support neuron survival, growth of new connections, and synaptic plasticity. This is the proposed basis for any longer-term effects; it has not been established in humans.
Russian animal research reports neuroprotective effects in several brain-ischemia models and improved blood rheology (PMID: 12596521), plus less tissue damage after experimentally induced thrombosis of cortical blood vessels (PMID: 12962045). Whether Noopept improves cerebral blood flow in people has not been shown.
Noopept shows neuroprotective effects in cell models: it reduced oxidative damage and lipid peroxidation in cultured human cortical neurons (PMID: 12711349) and protected cells against beta-amyloid toxicity, an Alzheimer's model (PMID: 25096780). Russian researchers also report it reduces the neurotoxic effects of excess calcium and glutamate (PMID: 12962045). Whether this translates to meaningful protection in healthy humans at standard doses is unclear.
What Russian Clinical Trials Show
Most Noopept clinical data comes from Russian studies. The evidence is real but limited: small populations, limited trial quality by Western standards. Here's an honest summary.
Noopept Dosing Protocol
There is no published evidence that higher doses work better. The only figures below come from the cited Russian research.
| Context | Dose | Frequency | Notes |
|---|---|---|---|
| Clinical study dose | 20mg/day | Daily for 2 months | The dose used in the open-label Russian stroke study above (PMID: 22500312). The study abstract does not say how the daily dose was divided. |
| Tablet strengths | 5mg and 10mg | Tablet sizes, not a schedule | The Russian Noopept tablets under clinical assessment in the early 2000s came in 5 and 10mg strengths (PMID: 12596521). |
| Cycling | Optional | On/off periods | Common user practice. Tolerance and cycling are unstudied in humans. |
| Choline Stack | Optional alpha-GPC | With Noopept | Common user practice, anecdotally for headaches. Not studied with Noopept. |
Many users take Noopept sublingually (holding powder or solution under the tongue before swallowing), expecting faster onset or a lower effective dose. We found no published human study comparing sublingual and oral Noopept, so those benefits are anecdotal. Russian researchers report the drug is active when taken orally (PMID: 12596521).
Key Takeaways
- Rat studies link its effects to glutamate (NMDA/AMPA) receptors; the mechanism is still being worked out
- Increased hippocampal BDNF/NGF expression in rat studies (PMID: 19240853)
- Small open-label Russian research reports cognitive improvement in stroke patients with mild cognitive impairment (PMID: 22500312)
- Reported as well tolerated in short-term Russian clinical use (20mg/day for 2 months) (PMID: 22500312)
- Developed in Russia in the 1990s as a novel dipeptide drug; still in Phase 2 clinical trials there in the early 2000s (PMID: 12962042)
- Western RCT evidence is very limited: most data from Russia
- Long-term safety profile in humans is poorly studied
- Whether BDNF benefits in animals translate to humans at normal doses
- Optimal cycling protocols for preventing tolerance
- Genuine benefit for healthy young adults vs impaired populations
Recommended Products
Many users stack Noopept with a choline source. These are the common picks.
Affiliate links support HighPeptides at no extra cost.
Educational content only. Noopept is not FDA-approved. Not medical advice. Consult a healthcare provider before use. The HighPeptides Research Team is not responsible for any health outcomes from use of information on this page.
Research-Grade Peptides
Swiss Chems
Our affiliate source for Noopept powder. Check the product page for current lab-testing documentation before buying.
Browse Swiss Chems Peptides →Affiliate links support HighPeptides at no extra cost.
Recommended Products
Relevant supplies for nootropics.
Affiliate links support HighPeptides at no extra cost.
Disclaimer
This page is for educational and informational purposes only. It is not medical advice. Always consult with a qualified healthcare provider before starting any supplement or medication. Key claims are cited inline to PubMed; much of the underlying research comes from small Russian animal and clinical studies. HighPeptides may receive affiliate compensation from linked vendors.
67-page guide: protocols, dosing, sourcing. Everything in one place.
Get the guide: $19 (normally $29) → The Protocol & Stack Handbook ($19) The Protocol & Stack Handbook ($19) All ebooks & guides →Get the Free 2026 Peptide Protocol Stack
Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.